Coppertone, BAY1183345

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Jan 28, 2019 → Feb 25, 2019

About Coppertone, BAY1183345

Coppertone, BAY1183345 is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03841032. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT03841032Pre-clinicalCompleted